Record overview
Status and phase
Status: RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Qilu Pharmaceutical Co., Ltd.
Condition: Advanced/Metastatic Solid Tumors
NCT07102004
Study of MHB088C for Patients With Advanced Solid Malignant Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.